Louisiana’s Abortion Pill Controversy: A Threat to Patient Safety?
In a move that has sent shockwaves through the medical community, the state of Louisiana is set to become the first in the US to categorize two widely used abortion pills – mifepristone and misoprostol – as “controlled dangerous substances.” The reclassification, which takes effect on Tuesday, will make it more difficult for patients to access these medications, which can be used together to manage miscarriages and induce labor. But what exactly does this mean for patient safety? Continue reading “Louisiana’s abortion pill controversy”